Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Esophageal and/or Gastric VaricesHepatocellular Carcinoma (HCC)
Interventions
PROCEDURE

Esophageal band ligation

upper endoscopy will be performed within 6 months before starting atezolizumab-bevacizumab therapy in HCC patients. Esophageal band ligation for small non-risky varices before starting atezolizumab-bevacizumab therapy. Endoscopy will be repeated 3, 5, 9, 12 months after atezolizumab-bevacizumab therapy

Trial Locations (1)

31516

RECRUITING

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER